Bioceltix S.A. (XI3)
FSX
Real-time Data
06:00 AM
Day's Range
20.4052 wk Range
13.98Overview - XI3 - Bioceltix S.A.
Key Statistics
Valuation
Enterprise Value
44.77M
P/E (Trailing)
‪-6.73‬
PEG Ratio
‪-0.19‬
Price / Book
‪2.61‬
EV / EBITDA
‪-3.13‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-19.45%‬
Return on Equity
‪-33.34%‬
Ownership
Shares Outstanding
5.53M
Float
4.43M
Held by Insiders
‪15.12%‬
Held by Institutions
‪28.87%‬
Price stats
Beta
‪0.90‬
50-Day Avg
‪20.04‬
200-Day Avg
‪18.10‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - XI3 - Bioceltix S.A.
Peers - XI3 - Bioceltix S.A.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- XI3FSXBioceltix S.A.112.85MMarket Cap-32.84%52-week change-6.73P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - XI3 - Bioceltix S.A.
About
Bioceltix S.A. is a biotechnology company focused on developing and commercializing innovative veterinary biomedicines. Its primary function is to enhance animal health through products designed for companion animals and livestock. Leveraging advancements in cell therapy and biologics, Bioceltix aims to address unmet…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
